» Articles » PMID: 33182684

Laryngopharyngeal Reflux: A State-of-the-Art Algorithm Management for Primary Care Physicians

Overview
Journal J Clin Med
Specialty General Medicine
Date 2020 Nov 13
PMID 33182684
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Laryngopharyngeal reflux (LPR) is a common disease in the general population with acute or chronic symptoms. LPR is often misdiagnosed in primary care because of the lack of typical gastroesophageal reflux disease (GERD) symptoms and findings on endoscopy. Depending on the physician's specialty and experience, LPR may be over- or under-diagnosed. Management of LPR is potentially entirely feasible in primary care as long as General Practitioners (GPs) are aware of certain "red flags" that will prompt referral to a Gastroenterologist or an Otolaryngologist. The use of patient-reported outcome questionnaires and the consideration of some easy ways to diagnose LPR without special instrumentation oropharyngeal findings may help the GP to diagnose and often manage LPR. In this review, we provide a practical algorithm for LPR management for GPs and other specialists that cannot perform fiberoptic examination. In this algorithm, physicians have to exclude some confounding conditions such as allergy or other causes of pharyngolaryngitis and "red flags". They may prescribe an empirical treatment based on diet and behavioral changes with or without medication, depending on the symptom severity. Proton pump inhibitors and alginates remain a popular choice in order to protect the upper aerodigestive tract mucosa from acid, weakly acid and alkaline pharyngeal reflux events.

Citing Articles

The Inhibitory Effect of and Coptidis Rhizome Mixture in the Pathogenesis of Laryngopharyngeal Reflux: Cleavage of E-Cadherin in Acid-Exposed Primary Human Pharyngeal Epithelial Cells.

Im N, Kim B, Chung Y, Jung K, Kim Y, Baek S Int J Mol Sci. 2024; 25(22).

PMID: 39596310 PMC: 11595113. DOI: 10.3390/ijms252212244.


Laryngopharyngeal Reflux Pathophysiology, Clinical Presentation, and Management: A Narrative Review.

Barham W, Alvarez-Amado A, Dillman K, Thibodeaux E, Nguyen I, Varrassi G Cureus. 2024; 16(8):e67305.

PMID: 39301397 PMC: 11412619. DOI: 10.7759/cureus.67305.


Narrative review of relationship between chronic cough and laryngopharyngeal reflux.

Hrankova V, Balner T, Gubova P, Stanikova L, Zelenik K, Kominek P Front Med (Lausanne). 2024; 11:1348985.

PMID: 38707186 PMC: 11066273. DOI: 10.3389/fmed.2024.1348985.


The Impact of Nutrition on the Onset, Course of Disease and Quality of Life of Patients with Laryngopharyngeal Reflux.

Prpic T, Pecek Prpic M, Mendes T, Sestak A, Vceva A Food Technol Biotechnol. 2024; 61(4):505-513.

PMID: 38205049 PMC: 10775783. DOI: 10.17113/ftb.61.04.23.8222.


Knowledge, attitudes and practices of patients with chronic pharyngitis toward laryngopharyngeal reflux in Suzhou, China.

Zhang Q, Huang H, Li J, Niu Y, Sun P, Cheng F BMC Public Health. 2023; 23(1):2542.

PMID: 38115020 PMC: 10731724. DOI: 10.1186/s12889-023-17463-0.


References
1.
Perry K, Enestvedt C, Lorenzo C, Schipper P, Schindler J, Morris C . The integrity of esophagogastric junction anatomy in patients with isolated laryngopharyngeal reflux symptoms. J Gastrointest Surg. 2008; 12(11):1880-7. DOI: 10.1007/s11605-008-0607-7. View

2.
Bobin F, Journe F, Lechien J . Saliva pepsin level of laryngopharyngeal reflux patients is not correlated with reflux episodes. Laryngoscope. 2019; 130(5):1278-1281. DOI: 10.1002/lary.28260. View

3.
Karkos P, Thomas L, Temple R, Issing W . Awareness of general practitioners towards treatment of laryngopharyngeal reflux: a British survey. Otolaryngol Head Neck Surg. 2005; 133(4):505-8. DOI: 10.1016/j.otohns.2005.06.013. View

4.
Ren J, Zhao Y, Wang J, Ren X, Xu Y, Tang W . PepsinA as a Marker of Laryngopharyngeal Reflux Detected in Chronic Rhinosinusitis Patients. Otolaryngol Head Neck Surg. 2017; 156(5):893-900. DOI: 10.1177/0194599817697055. View

5.
Richter J . Current Diagnosis and Management of Suspected Reflux Symptoms Refractory to Proton Pump Inhibitor Therapy. Gastroenterol Hepatol (N Y). 2016; 10(9):547-55. PMC: 4991531. View